₹308.25-6.25 (-1.99%)
02:39 PM, 5-Dec-2025₹307.95-6.05 (-1.93%)
02:24 PM, 5-Dec-2025BSE : 540025
NSE : ADVENZYMES
Sector : Health care
ISIN Code : INE837H01020
Last Updated: 05-Dec-2025 | 02:39 PM IST
| Market Cap (₹ Cr) | 3,451 |
Traded Value (₹ Cr) | 0.22 |
Volume (Shares) | 7,118 |
Face Value (₹) | 2 |
52-Week High (₹) | 411.80 |
52-Week High Date | 11-Dec-2024 |
52-Week Low (₹) | 257.85 |
52-Week Low Date | 03-Mar-2025 |
All Time High (₹) | 571.15 |
All Time High Date | 16-Sep-2024 |
All Time Low (₹) | 91.05 |
All Time Low Date | 23-Mar-2020 |
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 3,448 |
| EPS - TTM (₹) [C] | 13.47 |
| P/E Ratio (X) [C] | 22.86 |
| Face Value (₹) | 2 |
| Latest Dividend (%) | 60.00 |
| Latest Dividend Date | 23-Jul-2025 |
| Dividend Yield (%) | 1.66 |
| Book Value Share (₹) [C] | 132.64 |
| P/B Ratio (₹) [C] | 2.32 |
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| UTI-MNC Fund (G) | 31.97 | 10,37,821 | 1.10 |
| UTI-MNC Fund (IDCW) | 31.97 | 10,37,821 | 1.10 |
| UTI-MNC Fund - Direct (G) | 31.97 | 10,37,821 | 1.10 |
| UTI-MNC Fund - Direct (IDCW) | 31.97 | 10,37,821 | 1.10 |
| ICICI Pru ESG Exclusionary Strategy Fund-Dir (G) | 26.86 | 8,72,022 | 1.76 |
| ICICI Pru ESG Exclusionary Strategy Fund-Dir (IDCW) | 26.86 | 8,72,022 | 1.76 |
| ICICI Pru ESG Exclusionary Strategy Fund-Reg (IDCW) | 26.86 | 8,72,022 | 1.76 |
| ICICI Pru ESG Exclusionary Strategy Fund-Reg (G) | 26.86 | 8,72,022 | 1.76 |
| Bank of India Small Cap Fund (G) | 8.32 | 2,70,000 | 0.41 |
| Bank of India Small Cap Fund (IDCW) | 8.32 | 2,70,000 | 0.41 |
Load more
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
| Today's Low/High (₹) | 306.20 315.05 |
| Week Low/High (₹) | 306.20 319.00 |
| Month Low/High (₹) | 304.30 353.00 |
| Year Low/High (₹) | 257.90 411.00 |
| All time Low/High (₹) | 91.05 571.00 |
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -1.30% | -1.20% | -0.12% | -0.15% |
| 1 Month | -1.85% | -1.91% | 2.57% | 2.21% |
| 3 Month | -9.49% | -9.48% | 6.07% | 5.75% |
| 6 Month | 1.13% | 1.18% | 5.11% | 5.71% |
| 1 Year | -18.02% | -18.02% | 4.70% | 5.89% |
| 3 Year | 0.13% | 0.26% | 36.24% | 39.91% |
Whole-time director : MUKUND MADHUSUDAN KABRA
Chairman (Non-Executive) : VASANT RATHI
Independent Director : Pramod Kasat
Company Sec. & Compli. Officer : Sanjay Basantani
Non-Executive & Non-Independent Director : Rasika Rathi
Independent Director : Vindokumar Hiralal Jajoo
Non-Executive & Non-Independent Director : Sunny Sharma
Independent Director : Rajshree Patel
Independent Director : NITIN JAGANNATH DESHMUKH
Independent Director : Vandana Tilak.
Registered Office: Sun Magnetica 5th Floor, Nr LIC Serivce Road Louiswadi,Thane,Maharashtra-400604 Ph: 91-22-41703200
1. What's the Advanced Enzyme Technologies Ltd share price today?
Advanced Enzyme Technologies Ltd share price was Rs 308.25 at 02:39 PM IST on 5th Dec 2025. Advanced Enzyme Technologies Ltd share price was down by 1.99% from the previous closing price of Rs 314.50. Advanced Enzyme Technologies Ltd share price trend:
2. How can I quickly analyse the performance of the Advanced Enzyme Technologies Ltd stock?
The performance of the Advanced Enzyme Technologies Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Advanced Enzyme Technologies Ltd?
Advanced Enzyme Technologies Ltd has a market capitalisation of Rs 3,451 crore.
4. What is Advanced Enzyme Technologies Ltd's 52-week high/low share price?
The Advanced Enzyme Technologies Ltd’s 52-week high share price is Rs 411.80 and 52-week low share price is Rs 257.85.
5. Is the Advanced Enzyme Technologies Ltd profitable?
On a consolidated basis, Advanced Enzyme Technologies Ltd reported a profit of Rs 44.73 crore on a total income of Rs 194.81 crore for the quarter ended 2025.
6. Which are Advanced Enzyme Technologies Ltd’s peers in the Health care sector?
Advanced Enzyme Technologies Ltd’s top 5 peers in the Health care sector are Senores Pharma., Gufic BioScience, Dishman Carbogen, Advanced Enzyme, Unichem Labs., Hikal, SMS Pharma..
7. Who owns how much in Advanced Enzyme Technologies Ltd?
Key changes to the Advanced Enzyme Technologies Ltd shareholding are as follows: